Personalized Medicine Market Size, Share & Trends Analysis Report By Product (Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness), By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Information Procurement
                    1.2. Information Or Data Analysis
                    1.3. Market Scope & Segment Definition
                    1.4. Market Model
                         1.4.1. Market Study, By Company Market Share
                         1.4.2. Regional Analysis
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                         3.1.1. Parent Market Outlook
                         3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                         3.2.1. Market Driver Analysis
                              3.2.1.1. Utility Of Human Genome Data For Clinical Research
                                   3.2.1.1.1. Targeted And Personalized Healthcare
                              3.2.1.2. Technological Advancements To Facilitate R&D For Personalized Medicine
                                   3.2.1.2.1. Emergence Of Advanced Genome Editing Techniques
                                   3.2.1.2.2. Utility Of Novel Databases For Research
                         3.2.2. Market Restraint Analysis
                              3.2.2.1. Ethical Issues And Protection Of Individual’s Genomic Data
                              3.2.2.2. Limited Access To Human Genome Data And Databases
                         3.2.3. Market Opportunity Analysis
                    3.3. Industry Analysis Tools
                         3.3.1. Porter’s Five Forces Analysis
                         3.3.2. PESTEL Analysis
                         3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
                    4.1. Personalized Medicine Market: Product Movement Analysis
                    4.2. Personalized Medicine Diagnostics
                         4.2.1. Personalized Medicine Diagnostics Market, 2018 - 2030 (USD Billion)
                         4.2.2. Genetic Testing
                              4.2.2.1. Genetic Testing Market, 2018 - 2030 (USD Billion)
                         4.2.3. Direct-To-Consumer (DTC) Diagnostics
                              4.2.3.1. Direct-To-Consumer (DTC) Diagnostics Market, 2018 - 2030 (USD Billion)
                         4.2.4. Esoteric Lab Services
                              4.2.4.1. Esoteric Lab Services Market, 2018 - 2030 (USD Billion)
                         4.2.5. Esoteric Lab Tests
                              4.2.5.1. Esoteric Lab Tests Market, 2018 - 2030 (USD Billion)
                    4.3. Personalized Medicine Therapeutics
                         4.3.1. Personalized Medicine Therapeutics Market, 2018 - 2030 (USD Billion)
                         4.3.2. Pharmaceutical
                              4.3.2.1. Pharamceutical Market, 2018 - 2030 (USD Billion)
                         4.3.3. Genomic Medicine
                              4.3.3.1. Genomic Medicine Market, 2018 - 2030 (USD Billion)
                         4.3.4. Medical Devices
                              4.3.4.1. Medical Devices Market, 2018 - 2030 (USD Billion)
                    4.4. Personalized Medical Care
                         4.4.1. Personlaized Medical Care Market, 2018 - 2030 (USD Billion)
                         4.4.2. Telemedicine
                              4.4.2.1. Telemedicine Market, 2018 - 2030 (USD Billion)
                         4.4.3. Health Information Technology
                              4.4.3.1. Health Inforamtion Technology Market, 2018 - 2030 (USD Billion)
                    4.5. Personalized Nutrition & Wellness
                         4.5.1. Personalzied Nutrtion & Wellness Market, 2018 - 2030 (USD Billion)
                         4.5.2. Retail Nutrition
                              4.5.2.1. Retail Nutrition Market, 2018 - 2030 (USD Billion)
                         4.5.3. Complementary & Alternative Medicine
                              4.5.3.1. Complementary & Alternative Medicine Market, 2018 - 2030 (USD Billion)
Chapter 5. Regional Business Analysis
                    5.1. Personalized Medicine Market Share By Region, 2022 & 2030
                    5.2. North America
                         5.2.1. SWOT Analysis
                         5.2.2. North America Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.2.3. U.S.
                              5.2.3.1. Key Country Dynamics
                              5.2.3.2. Target Disease Prevalence
                              5.2.3.3. Competitive Scenario
                              5.2.3.4. Regulatory Framework
                              5.2.3.5. Reimbursement Scenario
                              5.2.3.6. U.S. Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.2.4. Canada
                              5.2.4.1. Key Country Dynamics
                              5.2.4.2. Target Disease Prevalence
                              5.2.4.3. Competitive Scenario
                              5.2.4.4. Regulatory Framework
                              5.2.4.5. Reimbursement Scenario
                              5.2.4.6. Canada Personalized Medicine Market, 2018 - 2030 (USD Billion)
                    5.3. Europe
                         5.3.1. SWOT Analysis
                         5.3.2. Europe Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.3.3. UK
                              5.3.3.1. Key Country Dynamics
                              5.3.3.2. Target Disease Prevalence
                              5.3.3.3. Competitive Scenario
                              5.3.3.4. Regulatory Framework
                              5.3.3.5. Reimbursement Scenario
                              5.3.3.6. UK Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.3.4. Germany
                              5.3.4.1. Key Country Dynamics
                              5.3.4.2. Target Disease Prevalence
                              5.3.4.3. Competitive Scenario
                              5.3.4.4. Regulatory Framework
                              5.3.4.5. Reimbursement Scenario
                              5.3.4.6. Germany Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.3.5. France
                              5.3.5.1. Key Country Dynamics
                              5.3.5.2. Target Disease Prevalence
                              5.3.5.3. Competitive Scenario
                              5.3.5.4. Regulatory Framework
                              5.3.5.5. Reimbursement Scenario
                              5.3.5.6. France Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.3.6. Italy
                              5.3.6.1. Key Country Dynamics
                              5.3.6.2. Target Disease Prevalence
                              5.3.6.3. Competitive Scenario
                              5.3.6.4. Regulatory Framework
                              5.3.6.5. Reimbursement Scenario
                              5.3.6.6. Italy Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.3.7. Spain
                              5.3.7.1. Key Country Dynamics
                              5.3.7.2. Target Disease Prevalence
                              5.3.7.3. Competitive Scenario
                              5.3.7.4. Regulatory Framework
                              5.3.7.5. Reimbursement Scenario
                              5.3.7.6. Spain Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.3.8. Denmark
                              5.3.8.1. Key Country Dynamics
                              5.3.8.2. Target Disease Prevalence
                              5.3.8.3. Competitive Scenario
                              5.3.8.4. Regulatory Framework
                              5.3.8.5. Reimbursement Scenario
                              5.3.8.6. Denmark Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.3.9. Sweden
                              5.3.9.1. Key Country Dynamics
                              5.3.9.2. Target Disease Prevalence
                              5.3.9.3. Competitive Scenario
                              5.3.9.4. Regulatory Framework
                              5.3.9.5. Reimbursement Scenario
                              5.3.9.6. Sweden Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.3.10. Norway
                              5.3.10.1. Key Country Dynamics
                              5.3.10.2. Target Disease Prevalence
                              5.3.10.3. Competitive Scenario
                              5.3.10.4. Regulatory Framework
                              5.3.10.5. Reimbursement Scenario
                              5.3.10.6. Norway Personalized Medicine Market, 2018 - 2030 (USD Billion)
                    5.4. Asia Pacific
                         5.4.1. SWOT Analysis
                         5.4.2. Asia Pacific Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.4.3. Japan
                              5.4.3.1. Key Country Dynamics
                              5.4.3.2. Target Disease Prevalence
                              5.4.3.3. Competitive Scenario
                              5.4.3.4. Regulatory Framework
                              5.4.3.5. Reimbursement Scenario
                              5.4.3.6. Japan Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.4.4. China
                              5.4.4.1. Key Country Dynamics
                              5.4.4.2. Target Disease Prevalence
                              5.4.4.3. Competitive Scenario
                              5.4.4.4. Regulatory Framework
                              5.4.4.5. Reimbursement Scenario
                              5.4.4.6. China Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.4.5. India
                              5.4.5.1. Key Country Dynamics
                              5.4.5.2. Target Disease Prevalence
                              5.4.5.3. Competitive Scenario
                              5.4.5.4. Regulatory Framework
                              5.4.5.5. Reimbursement Scenario
                              5.4.5.6. India Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.4.6. Australia
                              5.4.6.1. Key Country Dynamics
                              5.4.6.2. Target Disease Prevalence
                              5.4.6.3. Competitive Scenario
                              5.4.6.4. Regulatory Framework
                              5.4.6.5. Reimbursement Scenario
                              5.4.6.6. Australia Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.4.7. Thailand
                              5.4.7.1. Key Country Dynamics
                              5.4.7.2. Target Disease Prevalence
                              5.4.7.3. Competitive Scenario
                              5.4.7.4. Regulatory Framework
                              5.4.7.5. Reimbursement Scenario
                              5.4.7.6. Thailand Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.4.8. South Korea
                              5.4.8.1. Key Country Dynamics
                              5.4.8.2. Target Disease Prevalence
                              5.4.8.3. Competitive Scenario
                              5.4.8.4. Regulatory Framework
                              5.4.8.5. Reimbursement Scenario
                              5.4.8.6. South Korea Personalized Medicine Market, 2018 - 2030 (USD Billion)
                    5.5. Latin America
                         5.5.1. SWOT Analysis
                         5.5.2. Latin America Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.5.3. Brazil
                              5.5.3.1. Key Country Dynamics
                              5.5.3.2. Target Disease Prevalence
                              5.5.3.3. Competitive Scenario
                              5.5.3.4. Regulatory Framework
                              5.5.3.5. Reimbursement Scenario
                              5.5.3.6. Brazil Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.5.4. Mexico
                              5.5.4.1. Key Country Dynamics
                              5.5.4.2. Target Disease Prevalence
                              5.5.4.3. Competitive Scenario
                              5.5.4.4. Regulatory Framework
                              5.5.4.5. Reimbursement Scenario
                              5.5.4.6. Mexico Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.5.5. Argentina
                              5.5.5.1. Key Country Dynamics
                              5.5.5.2. Target Disease Prevalence
                              5.5.5.3. Competitive Scenario
                              5.5.5.4. Regulatory Framework
                              5.5.5.5. Reimbursement Scenario
                              5.5.5.6. Argentina Personalized Medicine Market, 2018 - 2030 (USD Billion)
                    5.6. MEA
                         5.6.1. SWOT Analysis
                         5.6.2. MEA Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.6.3. South Africa
                              5.6.3.1. Key Country Dynamics
                              5.6.3.2. Target Disease Prevalence
                              5.6.3.3. Competitive Scenario
                              5.6.3.4. Regulatory Framework
                              5.6.3.5. Reimbursement Scenario
                              5.6.3.6. South Africa Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.6.4. Saudi Arabia
                              5.6.4.1. Key Country Dynamics
                              5.6.4.2. Target Disease Prevalence
                              5.6.4.3. Competitive Scenario
                              5.6.4.4. Regulatory Framework
                              5.6.4.5. Reimbursement Scenario
                              5.6.4.6. Saudi Arabia Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.6.5. UAE
                              5.6.5.1. Key Country Dynamics
                              5.6.5.2. Target Disease Prevalence
                              5.6.5.3. Competitive Scenario
                              5.6.5.4. Regulatory Framework
                              5.6.5.5. Reimbursement Scenario
                              5.6.5.6. UAE Personalized Medicine Market, 2018 - 2030 (USD Billion)
                         5.6.6. Kuwait
                              5.6.6.1. Key Country Dynamics
                              5.6.6.2. Target Disease Prevalence
                              5.6.6.3. Competitive Scenario
                              5.6.6.4. Regulatory Framework
                              5.6.6.5. Reimbursement Scenario
                              5.6.6.6. Kuwait Personalized Medicine Market, 2018 - 2030 (USD Billion)
Chapter 6. Competitive Landscape
                    6.1. Company Categorization
                    6.2. Strategy Mapping
                    6.3. Company Market Share Analysis, 2022
                    6.4. Company Profiles/Listing
                         6.4.1. GE Healthcare
                              6.4.1.1. Overview
                              6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.1.3. Product Benchmarking
                              6.4.1.4. Strategic Initiatives
                         6.4.2. Illumina, Inc.
                              6.4.2.1. Overview
                              6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.2.3. Product Benchmarking
                              6.4.2.4. Strategic Initiatives
                         6.4.3. ASURAGEN, INC.
                              6.4.3.1. Overview
                              6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.3.3. Product Benchmarking
                              6.4.3.4. Strategic Initiatives
                         6.4.4. Abbott
                              6.4.4.1. Overview
                              6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.4.3. Product Benchmarking
                              6.4.4.4. Strategic Initiatives
                         6.4.5. Dako A/S
                              6.4.5.1. Overview
                              6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.5.3. Product Benchmarking
                              6.4.5.4. Strategic Initiatives
                         6.4.6. Exact Sciences Corporation
                              6.4.6.1. Overview
                              6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.6.3. Product Benchmarking
                              6.4.6.4. Strategic Initiatives
                         6.4.7. Danaher Corporation (Cepheid, Inc.)
                              6.4.7.1. Overview
                              6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.7.3. Product Benchmarking
                              6.4.7.4. Strategic Initiatives
                         6.4.8. Decode Genetics, Inc.
                              6.4.8.1. Overview
                              6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.8.3. Product Benchmarking
                              6.4.8.4. Strategic Initiatives
                         6.4.9. QIAGEN
                              6.4.9.1. Overview
                              6.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.9.3. Product Benchmarking
                              6.4.9.4. Strategic Initiatives
                         6.4.10. Exagen Inc.
                              6.4.10.1. Overview
                              6.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.10.3. Product Benchmarking
                              6.4.10.4. Strategic Initiatives
                         6.4.11. Precision Biologics
                              6.4.11.1. Overview
                              6.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.11.3. Product Benchmarking
                              6.4.11.4. Strategic Initiatives
                         6.4.12. Celera Diagnostics LLC
                              6.4.12.1. Overview
                              6.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.12.3. Product Benchmarking
                              6.4.12.4. Strategic Initiatives
                         6.4.13. Biogen
                              6.4.13.1. Overview
                              6.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.13.3. Product Benchmarking
                              6.4.13.4. Strategic Initiatives
                         6.4.14. Genelex
                              6.4.14.1. Overview
                              6.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.14.3. Product Benchmarking
                              6.4.14.4. Strategic Initiatives
                         6.4.15. IBM
                              6.4.15.1. Overview
                              6.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.15.3. Product Benchmarking
                              6.4.15.4. Strategic Initiatives
                         6.4.16. Genentech, Inc.
                              6.4.16.1. Overview
                              6.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.16.3. Product Benchmarking
                              6.4.16.4. Strategic Initiatives
                         6.4.17. 23andMe, Inc.
                              6.4.17.1. Overview
                              6.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                              6.4.17.3. Product Benchmarking
                              6.4.17.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Global personalized medicine market, by region, 2018 - 2030 (USD Billion)
Table 3 Global personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 4 North America personalized medicine market, by country, 2018 - 2030 (USD Billion)
Table 5 North America personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 6 U.S. personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 7 Canada personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 8 Europe personalized medicine market, by country, 2018 - 2030 (USD Billion)
Table 9 Europe personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 10 Germany personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 11 UK personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 12 France personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 13 Italy personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 14 Spain personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 15 Denmark personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 16 Sweden personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 17 Norway personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 18 Asia Pacific personalized medicine market, by country, 2018 - 2030 (USD Billion)
Table 19 Asia Pacific personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 20 Japan personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 21 China personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 22 India personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 23 South Korea personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 24 Thailand personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 25 Australia personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 26 Latin America personalized medicine market, by country, 2018 - 2030 (USD Billion)
Table 27 Latin America personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 28 Brazil personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 29 Mexico personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 30 Argentina personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 31 MEA personalized medicine market, by country, 2018 - 2030 (USD Billion)
Table 32 MEA personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 33 South Africa personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 34 Saudi Arabia personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 35 UAE personalized medicine market, by product, 2018 - 2030 (USD Billion)
Table 36 Kuwait personalized medicine market, by product, 2018 - 2030 (USD Billion)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 Market formulation & validation
FIG. 7 Personalized medicine market segmentation
FIG. 8 Market snapshot, 2022
FIG. 9 Market trends & outlook
FIG. 10 Market driver relevance analysis (current & future impact)
FIG. 11 Market restraint relevance analysis (current & future impact)
FIG. 12 PESTEL analysis
FIG. 13 Porter’s five forces analysis
FIG. 14 Global personalized medicine market, for product, 2018 - 2030 (USD Billion)
FIG. 15 Global personalized medicine market, for diagnostics, 2018 - 2030 (USD Billion)
FIG. 16 Global personalized medicine market, for genetic testing, 2018 - 2030 (USD Billion)
FIG. 17 Global personalized medicine market, for Direct-To-Consumer (DTC) testing, 2018 - 2030 (USD Billion)
FIG. 18 Global personalized medicine market, for esoteric lab services, 2018 - 2030 (USD Billion)
FIG. 19 Global personalized medicine market, for esoteric lab tests, 2018 - 2030 (USD Billion)
FIG. 20 Global personalized medicine market, for therapeutics, 2018 - 2030 (USD Billion)
FIG. 21 Global personalized medicine market, for pharmaceutical, 2018 - 2030 (USD Billion)
FIG. 22 Global personalized medicine market, for genomic medicine, 2018 - 2030 (USD Billion)
FIG. 23 Global personalized medicine market, for medical devices, 2018 - 2030 (USD Billion)
FIG. 24 Global personalized medicine market, for personalized medical care, 2018 - 2030 (USD Billion)
FIG. 25 Global personalized medicine market, for telemedicine, 2018 - 2030 (USD Billion)
FIG. 26 Global personalized medicine market, for health information technology, 2018 - 2030 (USD Billion)
FIG. 27 Global personalized medicine market, for personalized nutrition & wellness, 2018 - 2030 (USD Billion)
FIG. 28 Global personalized medicine market, for retail nutrition, 2018 - 2030 (USD Billion)
FIG. 29 Global personalized medicine market, for complementary & alternative medicine, 2018 - 2030 (USD Billion)
FIG. 30 Regional outlook, 2022 & 2030
FIG. 31 North America personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 32 U.S. personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 33 Canada personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 34 Europe personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 35 Germany personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 36 UK personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 37 France personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 38 Italy personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 39 Spain personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 40 Denmark personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 41 Sweden personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 42 Norway personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 43 Asia Pacific personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 44 Japan personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 45 China personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 46 India personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 47 Australia personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 48 Thailand personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 49 South Korea personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 50 Latin America personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 51 Brazil personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 52 Mexico personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 53 Argentina personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 54 MEA personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 55 South Africa personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 56 Saudi Arabia personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 57 UAE personalized medicine market, 2018 - 2030 (USD Billion)
FIG. 58 Kuwait personalized medicine market, 2018 - 2030 (USD Billion)